Eltair | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Eltair
Annual Reports

PharmaCompass Sponsored Ads

Contact Supplier

Coral Budesonide

Contact Supplier

pharmacompass-1-m-2025-12-22

PharmaCompass Sponsored Ads

Contact Supplier

HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

Contact Supplier

pharmacompass-2-m-2025-11-03

Eltair

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

94 API Suppliers, 26 USDMF, 29 CEP/COS, 7 JDMF, 8 EU WC, 19 KDMF, 38 NDC API, 47 Listed Suppliers, $ API Reference Price

94 API Suppliers
26 USDMF
29 CEP/COS
7 JDMF
8 EU WC
19 KDMF
38 NDC API
47 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

269 Drugs in Development

269 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1262 FDF Dossiers, 54 FDA Orange Book, 1016 Europe, 23 Canada, 75 Australia, 39 South Africa, 55 Listed Dossiers

1262 FDF Dossiers
54 FDA Orange Book
1016 Europe
23 Canada
75 Australia
39 South Africa
55 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 9MG, AEROSOL, FOAM;RECTAL - 2MG/ACTUATION, SPRAY, METERED;NASAL - 0.032MG/SPRAY, SUSPENSION;INHALATION - 0.25MG/2ML, SUSPENSION;INHALATION - 0.5MG/2ML, SUSPENSION;INHALATION - 1MG/2ML, CAPSULE, DELAYED RELEASE;ORAL - 6MG, CAPSULE, DELAYED RELEASE;ORAL - 9MG, CAPSULE, DELAYED RELEASE;ORAL - 3MG, AEROSOL, METERED;INHALATION - 0.08MG/INH;0.0045MG/INH, AEROSOL, METERED;INHALATION - 0.16MG/INH;0.0045MG/INH

TABLET, EXTENDED RELEASE;ORAL - 9MG
AEROSOL, FOAM;RECTAL - 2MG/ACTUATION
SPRAY, METERED;NASAL - 0.032MG/SPRAY
SUSPENSION;INHALATION - 0.25MG/2ML
SUSPENSION;INHALATION - 0.5MG/2ML
SUSPENSION;INHALATION - 1MG/2ML
CAPSULE, DELAYED RELEASE;ORAL - 6MG
CAPSULE, DELAYED RELEASE;ORAL - 9MG
CAPSULE, DELAYED RELEASE;ORAL - 3MG
AEROSOL, METERED;INHALATION - 0.08MG/INH;0.0045MG/INH
AEROSOL, METERED;INHALATION - 0.16MG/INH;0.0045MG/INH

RELATED EXCIPIENT COMPANIES

4 Evonik, 1 Rochem International Inc, 5 SPI Pharma, 13 DKSH, 3 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 9 Kirsch Pharma, 4 ACG Worldwide, 11 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 23 BASF, 1 CD Formulation, 1 Clariant, 14 Corel Pharma Chem, 4 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 10 Gangwal Chemicals, 8 Ideal Cures, 2 Ingredion Pharma Solutions, 20 Kerry, 2 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 18 Roquette, 14 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 Silverline Chemicals, 4 The Dow Chemical Company, 2 Valens Pharmachem, 2 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

64 Coating Systems & Additives, 53 Fillers, Diluents & Binders, 42 Thickeners and Stabilizers, 35 Controlled & Modified Release, 25 Solubilizers, 23 Granulation, 23 Direct Compression, 20 Parenteral, 20 Film Formers & Plasticizers, 20 Taste Masking, 19 Topical, 18 Lubricants & Glidants, 11 Co-Processed Excipients, 10 Emulsifying Agents, 10 Rheology Modifiers, 9 Empty Capsules, 9 Disintegrants & Superdisintegrants, 8 Chewable & Orodispersible Aids, 5 Surfactant & Foaming Agents, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules

64 Coating Systems & Additives
53 Fillers, Diluents & Binders
42 Thickeners and Stabilizers
35 Controlled & Modified Release
25 Solubilizers
23 Granulation
23 Direct Compression
20 Parenteral
20 Film Formers & Plasticizers
20 Taste Masking
19 Topical
18 Lubricants & Glidants
11 Co-Processed Excipients
10 Emulsifying Agents
10 Rheology Modifiers
9 Empty Capsules
9 Disintegrants & Superdisintegrants
8 Chewable & Orodispersible Aids
5 Surfactant & Foaming Agents
5 API Stability Enhancers
5 Coloring Agents
4 Vegetarian Capsules

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 2 Stock Recap #PipelineProspector, 146 News #PharmaBuzz

1 Data Compilation #PharmaFlow
2 Stock Recap #PipelineProspector
146 News #PharmaBuzz

GLOBAL SALES INFORMATION

34 US Medicaid Prescriptions, 186 Regulatory FDF Prices, 51 Annual Reports

34 US Medicaid Prescriptions
186 Regulatory FDF Prices
51 Annual Reports

MARKET PLACE

20 APIs, 17 FDF Dossiers, 1 EXCIPIENTS

20 APIs
17 FDF Dossiers
1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

39 US Patents, 4 US Exclusivities, 16 Health Canada Patents

39 US Patents
4 US Exclusivities
16 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 21 USP, 15 Others

2 EDQM
21 USP
15 Others

ANALYTICAL

3 BioAnalytical Methods

3 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 3,470 Xls

Filters

Reset all filters

Filters

FILTER :

filter Product Reset all filters

51 All

01 1Airsupra

02 6Breztri

03 4Cortiment

04 1Eohilia

05 11Pulmicort

06 21Symbicort

07 5Uceris

08 1Uceris/Cortiment

09 1Ultibro Group

Minakem Budesonide

List of Suppliers

Product Main Page

01

Brand Name : Symbicort

Budesonide, Formoterol

BIO Partnering at JPM

Not Confirmed

Brand Name : Symbicort

BIO Partnering at JPM

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Budesonide, Formoterol

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 0

2019 Revenue in Millions : 213

Growth (%) : -100

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Symbicort

Budesonide, Glycopyrronium, Formoterol Fumarate

BIO Partnering at JPM

Not Confirmed

Brand Name : Symbicort

BIO Partnering at JPM

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Budesonide, Glycopyrronium, Formoterol Fumarate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 0

2019 Revenue in Millions : 213

Growth (%) : -100

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Symbicort

Budesonide, Formoterol

BIO Partnering at JPM

Not Confirmed

Brand Name : Symbicort

BIO Partnering at JPM

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AstraZeneca

Budesonide, Formoterol

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 2,721

2019 Revenue in Millions : 2,495

Growth (%) : 9

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Cortiment

Budesonide, Glycopyrronium, Formoterol Fumarate

BIO Partnering at JPM

Not Confirmed

Brand Name : Cortiment

BIO Partnering at JPM

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Cosmo Pharmaceuticals

Budesonide, Glycopyrronium, Formoterol Fumarate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 8

2019 Revenue in Millions : 5

Growth (%) : 70

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Brand Name : Uceris

Budesonide, Glycopyrronium, Formoterol Fumarate

BIO Partnering at JPM

Not Confirmed

Brand Name : Uceris

BIO Partnering at JPM

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Cosmo Pharmaceuticals

Budesonide, Glycopyrronium, Formoterol Fumarate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 6

2019 Revenue in Millions : 11

Growth (%) : -48

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Brand Name : Breztri

Budesonide, Glycopyrronium, Formoterol Fumarate

BIO Partnering at JPM

Not Confirmed

Brand Name : Breztri

BIO Partnering at JPM

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AstraZeneca

Budesonide, Glycopyrronium, Formoterol Fumarate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 28

2019 Revenue in Millions : 2

Growth (%) : 1,300

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Brand Name : Symbicort

Budesonide, Glycopyrronium, Formoterol Fumarate

BIO Partnering at JPM

Not Confirmed

Brand Name : Symbicort

BIO Partnering at JPM

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AstraZeneca

Budesonide, Glycopyrronium, Formoterol Fumarate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 2,721

2019 Revenue in Millions : 2,495

Growth (%) : 9

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Brand Name : Pulmicort

Budesonide, Glycopyrronium, Formoterol Fumarate

BIO Partnering at JPM

Not Confirmed

Brand Name : Pulmicort

BIO Partnering at JPM

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AstraZeneca

Budesonide, Glycopyrronium, Formoterol Fumarate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 996

2019 Revenue in Millions : 1,466

Growth (%) : -32

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Brand Name : Pulmicort

Budesonide, Glycopyrronium, Formoterol Fumarate

BIO Partnering at JPM

Not Confirmed

Brand Name : Pulmicort

BIO Partnering at JPM

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AstraZeneca

Budesonide, Glycopyrronium, Formoterol Fumarate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2021 Revenue in Millions : 962

2020 Revenue in Millions : 996

Growth (%) : -3

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Brand Name : Uceris

Budesonide, Glycopyrronium, Formoterol Fumarate

BIO Partnering at JPM

Not Confirmed

Brand Name : Uceris

BIO Partnering at JPM

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Cosmo Pharmaceuticals

Budesonide, Glycopyrronium, Formoterol Fumarate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2021 Revenue in Millions : 4

2020 Revenue in Millions : 5

Growth (%) : -31

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.